BioVie, Inc. (BIVI)
1.43
+0.05
(+3.62%)
USD |
NASDAQ |
Oct 30, 16:00
1.42
-0.01
(-0.70%)
Pre-Market: 20:00
BioVie Net Income (Quarterly) : -5.646M for June 30, 2026
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -5.646M |
| March 31, 2026 | -5.270M |
| December 31, 2025 | -6.070M |
| September 30, 2025 | -5.088M |
| June 30, 2025 | -3.489M |
| March 31, 2025 | -2.788M |
| December 31, 2024 | -7.112M |
| September 30, 2024 | -4.152M |
| June 30, 2024 | -4.941M |
| March 31, 2024 | -8.068M |
| December 31, 2023 | -8.401M |
| September 30, 2023 | -10.71M |
| June 30, 2023 | -9.112M |
| March 31, 2023 | -15.04M |
| December 31, 2022 | -15.69M |
| September 30, 2022 | -10.42M |
| June 30, 2022 | -8.089M |
| March 31, 2022 | -7.041M |
| December 31, 2021 | -5.414M |
| September 30, 2021 | -5.541M |
| June 30, 2021 | -131.53M |
| March 31, 2021 | -2.993M |
| December 31, 2020 | -3.058M |
| September 30, 2020 | 7.334M |
| June 30, 2020 | -19.15M |
| Date | Value |
|---|---|
| March 31, 2020 | -0.3664M |
| December 31, 2019 | 6.665M |
| September 30, 2019 | -3.821M |
| June 30, 2019 | -0.6559M |
| March 31, 2019 | -0.848M |
| December 31, 2018 | -0.5005M |
| September 30, 2018 | -0.4399M |
| June 30, 2018 | -0.555M |
| March 31, 2018 | -0.6926M |
| December 31, 2017 | -0.5027M |
| September 30, 2017 | -0.6628M |
| June 30, 2017 | -0.443M |
| March 31, 2017 | -0.1785M |
| December 31, 2016 | -0.3578M |
| September 30, 2016 | -0.3513M |
| June 30, 2016 | -0.2697M |
| March 31, 2016 | -0.0578M |
| December 31, 2015 | -0.0499M |
| September 30, 2015 | -0.0546M |
| June 30, 2015 | -0.0548M |
| March 31, 2015 | -0.049M |
| December 31, 2014 | -0.0705M |
| September 30, 2014 | -0.0588M |
| June 30, 2014 | -0.1732M |
| March 31, 2014 | -0.048M |
Net Income Definition
Represents net income for the period and date(s) requested in local currency by default.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Agenus, Inc. | -0.567M |
| Amgen, Inc. | 2.375B |
| Anika Therapeutics, Inc. | 3.309M |
| BioCryst Pharmaceuticals, Inc. | 78.40M |
| Imunon, Inc. | -2.814M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 5.646M |
| EPS Diluted (Quarterly) | -0.7485 |
| Enterprise Value | 2.084M |
| Earnings Yield | -223.6% |
| Normalized Earnings Yield | -223.59 |